Percutaneous mitral valve interventions: Overview of new approaches

Current Cardiology Reports

Volumn 12, Issue 5, 2010, Pages 404-412

  Goldberg, Steven L ^a,b   Feldman, Ted ^c  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b Cardiac Dimensions Inc   (United States)

^c EVANSTON HOSPITAL   (United States)

Author keywords

Mitral regurgitation; Percutaneous therapy; Structural heart disease

Indexed keywords

CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HUMAN; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS MITRAL VALVE INTERVENTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

CORONARY SINUS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FLUOROSCOPY; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PROGNOSIS; RISK ASSESSMENT; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 77956267249     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0130-9     Document Type: Review

References (31)

1. Y Chandrashekhar S Westaby J Narula 2009 Mitral stenosis Lancet 374 1271 1283 10.1016/S0140-6736(09)60994-6 1:STN:280:DC%2BD1MnotlWitw%3D%3D 19747723
2. DS Blondheim LE Jacobs MN Kotler, et al. 1991 Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus Am Heart J 122 3 Pt 1 763 771 10.1016/0002-8703(91)90523-K 1:STN:280:DyaK3MzksVyhuw%3D%3D 1877453
3. G Cioffi L Tarantini S De Feo, et al. 2005 Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure Eur J Heart Fail 7 1112 1117 10.1016/j.ejheart.2005.01.016 15919238
4. A Junker P Thayssen B Nielsen PE Andersen 1993 The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy Cardiology 83 14 20 10.1159/000175942 1:STN:280:DyaK2c%2FosVOntg%3D%3D 8261482
5. TM Koelling KD Aaronson RJ Cody, et al. 2002 Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction Am Heart J 144 524 529 10.1067/mhj.2002.123575 12228791
6. JB Patel DD Borgeson ME Barnes, et al. 2004 Mitral regurgitation in patients with advanced systolic heart failure J Card Fail 10 285 291 10.1016/j.cardfail.2003.12.006 15309693
7. RH Strauss LW Stevenson BA Dadourian JS Child 1987 Predictability of mitral regurgitation detected by Doppler echocardiography in patients referred for cardiac transplantation Am J Cardiol 59 892 894 10.1016/0002-9149(87)91114-3 1:STN:280:DyaL2s7ltlWnsQ%3D%3D 3548306
8. BH Trichon DD Glower LK Shaw, et al. 2003 Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation Circulation 108 Suppl 1 II103 II110 12970217
9. H Tada J Tamai H Takaki, et al. 1997 Mild mitral regurgitation reduces exercise capacity in patients with idiopathic dilated cardiomyopathy Int J Cardiol 58 41 45 10.1016/S0167-5273(96)02839-2 1:STN:280:DyaK2s7ntlGhtA%3D%3D 9021426
10. P Lancellotti PL Gerard LA Pierard 2005 Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation Eur Heart J 26 1528 1532 10.1093/eurheartj/ehi189 15814566
11. P Lancellotti LA Pierard 2005 Chronic ischaemic mitral regurgitation: exercise testing reveals its dynamic component Eur Heart J 26 1816 1817 10.1093/eurheartj/ehi418 16055496
12. P Lancellotti P Troisfontaines AC Toussaint LA Pierard 2003 Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction Circulation 108 1713 1717 10.1161/01.CIR.0000087599.49332.05 12975251
13. R Lapu-Bula A Robert D Van Craeynest, et al. 2002 Contribution of exercise-induced mitral regurgitation to exercise stroke volume and exercise capacity in patients with left ventricular systolic dysfunction Circulation 106 1342 1348 10.1161/01.CIR.0000028812.98083.D9 12221050
14. VT Nkomo JM Gardin TN Skelton, et al. 2006 Burden of valvular heart diseases: a population-based study Lancet 368 1005 1011 10.1016/S0140-6736(06) 69208-8 16980116
15. DS Bach SF Bolling 1995 Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy Am Heart J 129 1165 1170 10.1016/0002-8703(95)90399-2 1:STN:280: DyaK2M3nsVGksQ%3D%3D 7754949
16. DS Bach SF Bolling 1996 Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty Am J Cardiol 78 966 969 10.1016/S0002-9149(96)00481-X 1:STN:280: DyaK2s%2FktlKjtQ%3D%3D 8888680
17. SF Bolling 2002 Mitral reconstruction in cardiomyopathy J Heart Valve Dis 11 Suppl 1 S26 S31 11843517
18. AH Wu KD Aaronson SF Bolling, et al. 2005 Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction J Am Coll Cardiol 45 381 387 10.1016/j.jacc.2004.09.073 15680716
19. RO Bonow BA Carabello K Chatterjee, et al. 2006 ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J Am Coll Cardiol 48 e1 e148 10.1016/j.jacc.2006.05.021 16875962
20. A Vahanian H Baumgartner J Bax, et al. 2007 Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 28 230 268 17259184
21. O Alfieri F Maisano M De Bonis, et al. 2001 The double-orifice technique in mitral valve repair: a simple solution for complex problems J Thorac Cardiovasc Surg 122 674 681 10.1067/mtc.2001.117277 1:STN:280: DC%2BD3MrjsVelsw%3D%3D 11581597
22. F Maisano JJ Schreuder M Oppizzi, et al. 2000 The double-orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique Eur J Cardiothorac Surg 17 201 205 10.1016/S1010-7940(00)00351-1 1:STN:280:DC%2BD3c3itlSiug%3D%3D 10758376
23. F Maisano L Torracca M Oppizzi, et al. 1998 The edge-to-edge technique: a simplified method to correct mitral insufficiency Eur J Cardiothorac Surg 13 240 245 10.1016/S1010-7940(98)00014-1 1:STN:280:DyaK1c3ptVegtA%3D%3D 9628372 discussion 245-246
24. T Feldman HS Wasserman HC Herrmann, et al. 2005 Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial J Am Coll Cardiol 46 2134 2140 10.1016/j.jacc.2005.07.065 16325053
25. T Feldman S Kar M Rinaldi, et al. 2009 Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort J Am Coll Cardiol 54 686 694 10.1016/j.jacc.2009.03.077 19679246 The results of 107 patients in the EVEREST and roll-in phase of the EVEREST II study were assessed from implant out to 3 years of follow-up. The investigators found that percutaneous repair with the MitraClip could be performed with a low incidence of morbidity and mortality and with a reduction in MR to less than 2 in the majority of patients, with sustained freedom from death, surgery, or recurrent MR in a substantial proportion
26. JG Webb J Harnek BI Munt, et al. 2006 Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus Circulation 113 851 855 10.1161/CIRCULATIONAHA.105.591602 16461812
27. S Sack P Kahlert L Bilodeau, et al. 2009 Percutaneous transvenous mitral annuloplasty: Initial human experience with a novel coronary sinus implant device Circ Cardiovasc Interv 2 1 9 10.1161/CIRCINTERVENTIONS.109.855205 This study assessed the safety and feasibility of the PTMA coronary sinus mitral repair device, looking at multiple iterations of the device. They noted sustained geometric modifications of the mitral annulus, supporting continued evaluation and development
28. J Schofer T Siminiak M Haude, et al. 2009 Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study Circulation 120 326 333 10.1161/CIRCULATIONAHA.109.849885 19597051 The AMADEUS study was a safety and efficacy study of the CARILLON Mitral Contour System XE device to treat functional MR. The investigators found a low rate of major adverse events using this device, with improvements in quality of life and exercise tolerance
29. JH Kim O Kocaturk C Ozturk, et al. 2009 Mitral cerclage annuloplasty, a novel transcatheter treatment for secondary mitral valve regurgitation: initial results in swine J Am Coll Cardiol 54 638 651 10.1016/j.jacc.2009.03.071 19660696
30. JH Rogers DA Rahdert GR Caputo, et al. 2009 Long-term safety and durability of percutaneous septal sinus shortening (The PS(3) System) in an ovine model Catheter Cardiovasc Interv 73 540 548 10.1002/ccd.21818 19235241
31. WR Pedersen P Block M Leon, et al. 2008 iCoapsys mitral valve repair system: Percutaneous implantation in an animal model Catheter Cardiovasc Interv 72 125 131 10.1002/ccd.21551 18561162